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p53 synthesis and enhances tumor cell killing by
p53 degradation blockage
Marcus J.G.W. Ladds, Ingeborg M.M. van Leeuwen, Catherine J. Drummond et al.#
Correction to: Nature Communications https://doi.org/10.1038/s41467-018-03441-3, published online 16 March 2018
The original PDF version of this Article listed the authors as “Marcus J.G.W. Ladds,” where it should have read “Marcus J. G. W.
Ladds, Ingeborg M. M. van Leeuwen, Catherine J. Drummond et al.#”.
Also in the PDF version, it was incorrectly stated that “Correspondence and requests for materials should be addressed to S. Lín.”,
instead of the correct “Correspondence and requests for materials should be addressed to S. Laín.”
This has been corrected in the PDF version of the Article. The HTML version was correct from the time of publication.
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